...
首页> 外文期刊>Journal for ImmunoTherapy of Cancer >P01.23?Creating a cell-culture based reporter system for the evaluation of molecular signaling mechanisms of inhibitory chimeric antigen receptors
【24h】

P01.23?Creating a cell-culture based reporter system for the evaluation of molecular signaling mechanisms of inhibitory chimeric antigen receptors

机译:P01.23?创造基于细胞培养的报告系统,用于评估抑制嵌合抗原受体的分子信号传导机制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Adoptive transfer of T cells expressing chimeric antigen receptors (CARs) is a novel treatment option for patients with B-cell lineage derived cancers. Other cancer entities are less successfully targeted due to the lack of antigens that are expressed on cancer cells but not healthy tissue cells. One way to address this issue is the concept of inhibitory chimeric antigen receptors (iCARs) that deliver an inhibitory signal upon antigen encounter on off-target cells. The activating effect of CARs depends on a multitude of factors including expression levels, affinity, different signaling domains and steric effects. It has to be expected that co-expression of an iCAR would result in even more complexity. Consequently, there is a demand for a robust high-throughput cellular system to evaluate iCAR-formats. Materials and Methods Our approach is based on a previously published Jurkat based triple parameter reporter cell (TPR) system. This setup allows for molecular monitoring of the T cell activation state by measuring fluorescent reporter gene expression via flow cytometry. Inhibitory effects of receptors are determined as the ratio of cellular geometric mean fluorescent intensity (gMFI) in the presence of the inhibitory ligand versus without inhibitory ligand. Results To test if inhibitory receptors would measurably reduce reporter activation, PD-1 as a well-characterized inhibitory receptor was expressed on Jurkat TPRs. When PD-L1 was present during stimulation reporter activation was reduced by 26–34% proving feasibility of our approach. Intracellular domains of other inhibitory receptors including BTLA, ILT-2 and KIR2DL1 were evaluated. All three domains outperformed PD-1 in a series of experiments with a mean reduction of gMFI by 48–57%, 50–53% and 38–41% respectively. To assess if the reporter platform could be used to study downstream signaling pathways of inhibitory constructs we created a SHP-2 knock-out reporter cell line using the CRISPR/Cas9 gene editing technique. To simulate different degrees of activating signal strength, peptide-MHC complex recognizing activating receptors were created. The reporter activation correlated with the concentrations of peptide in the stimulation cultures. Co-expression of iCAR and CAR could be achieved using selection for two separate antibiotic resistance genes introduced into the respective vector. Preliminary experiments showed greatly reduced inhibitory efficacy of iCAR molecules due to an adhesion effect resulting from the high affinity extracellular domain of the iCARs that lead to tighter cell-cell contact and stronger stimulation through the CAR. Conclusions We present a highly flexible and controllable Jurkat-based reporter cell platform for the thorough study of inhibitory signaling mechanisms. This project was supported by the Austrian Science Fund, FWF; Project P32411 Disclosure Information M.A. Funk: None. A. De Sousa Linhares: None. C. Battin: None. K. Radakovics: None. J. Leitner: None. P. Steinberger: None.
机译:背景技术表达嵌合抗原受体(汽车)的T细胞的养分转移是B细胞谱系衍生癌症患者的新型治疗选择。由于缺乏在癌细胞上表达但不健康的组织细胞,其他癌症实体较不成功靶向。解决这个问题的一种方法是抑制嵌合抗原受体(ICAR)的概念,其在抗靶细胞上以抗原遭遇递送抑制信号。汽车的激活效果取决于包括表达水平,亲和力,不同信号传导结构域和空间效应的多种因素。必须预期ICAR的共同表达会导致更复杂。因此,需要一种稳健的高吞吐量蜂窝系统来评估ICAR格式。材料和方法我们的方法是基于先前发布的Jurkat基三个参数报告器单元(TPR)系统。该设置允许通过通过流式细胞术测量荧光报告基因表达来对T细胞活化状态进行分子监测。受体的抑制作用被确定为细胞几何平均荧光强度(GMFI)在抑制性配体与没有抑制配体的情况下的比率。结果试验如果抑制受体会测量报告活化,则在JurkatTPRS上表达了作为表征良好的抑制受体的PD-1。当在刺激期间存在PD-L1,报告者激活减少了26-34%,证明了我们的方法可行性。评价包括BTLA,ILT-2和KIR2DL1在内的其他抑制受体的细胞内域。所有三个结构域都在一系列实验中表现出PD-1,平均降低GMFI 48-57%,50-53%和38-41%。为了评估报告平台可以用于研究抑制构建体的下游信号通路,我们使用CRISPr / Cas9基因编辑技术创建了SHP-2敲除报告细胞系。为了模拟不同程度的激活信号强度,产生批识激活受体的肽-MHC复合物。报告者激活与刺激培养物中肽的浓度相关。可以使用选择引入相应载体的两种单独的抗生素抗性基因的选择来实现ICAR和汽车的共表达。初步实验表明,由于icar的高亲和力细胞外结构域导致的粘附效果,导致细胞 - 细胞接触和通过汽车更强的刺激引起的粘附效果大大降低了icar分子的抑制作用。结论我们为基于高度灵活和可控的Jurkat的报告细胞平台提供了一种高度灵活和可控的Jurkat的报告细胞平台,用于彻底研究抑制信号传导机制。该项目得到了奥地利科学基金,FWF的支持;项目P32411披露信息M.A. Funk:无。 A. de Sousa Linhares:没有。 C. Battin:没有。 K. Radakovics:没有。 J. Leitner:无。 P. Steinberger:没有。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号